Walter Korz

733 total citations
14 papers, 584 citations indexed

About

Walter Korz is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Walter Korz has authored 14 papers receiving a total of 584 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 5 papers in Immunology and 4 papers in Molecular Biology. Recurrent topics in Walter Korz's work include Chemokine receptors and signaling (6 papers), Immunotherapy and Immune Responses (5 papers) and Pain Mechanisms and Treatments (4 papers). Walter Korz is often cited by papers focused on Chemokine receptors and signaling (6 papers), Immunotherapy and Immune Responses (5 papers) and Pain Mechanisms and Treatments (4 papers). Walter Korz collaborates with scholars based in United States, Canada and Taiwan. Walter Korz's co-authors include Donald Wong, Hassan Salari, Ahmed Merzouk, Pridvi Kandagatla, Sreenivasa R. Chinni, Chand Khanna, Brieanne Midura, Su Young Kim, Arnulfo Mendoza and Lee J. Helman and has published in prestigious journals such as Cancer Research, Clinical Cancer Research and Molecular Cancer Therapeutics.

In The Last Decade

Walter Korz

14 papers receiving 567 citations

Peers

Walter Korz
Eva Zebedin Austria
John Densmore United States
Li‐Fen Lee United States
D Oberberg Germany
Amber C. Donahue United States
Jane Addis Canada
Eva Zebedin Austria
Walter Korz
Citations per year, relative to Walter Korz Walter Korz (= 1×) peers Eva Zebedin

Countries citing papers authored by Walter Korz

Since Specialization
Citations

This map shows the geographic impact of Walter Korz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Walter Korz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Walter Korz more than expected).

Fields of papers citing papers by Walter Korz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Walter Korz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Walter Korz. The network helps show where Walter Korz may publish in the future.

Co-authorship network of co-authors of Walter Korz

This figure shows the co-authorship network connecting the top 25 collaborators of Walter Korz. A scholar is included among the top collaborators of Walter Korz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Walter Korz. Walter Korz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
3.
Hagen, Neil A., John Constant, Gilbert Blaise, et al.. (2017). Tetrodotoxin for Moderate to Severe Cancer-Related Pain: A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Design Trial. Pain Research and Management. 2017. 1–7. 54 indexed citations
4.
Salas, Margaux M., et al.. (2015). Tetrodotoxin suppresses thermal hyperalgesia and mechanical allodynia in a rat full thickness thermal injury pain model. Neuroscience Letters. 607. 108–113. 27 indexed citations
5.
Wong, Donald, Pridvi Kandagatla, Walter Korz, & Sreenivasa R. Chinni. (2014). Targeting CXCR4 with CTCE-9908 inhibits prostate tumor metastasis. BMC Urology. 14(1). 12–12. 61 indexed citations
6.
Kavsak, Peter A., Matthew Henderson, Patrícia Moretto, et al.. (2009). Biochip arrays for the discovery of a biomarker surrogate in a phase I/II study assessing a novel anti-metastasis agent. Clinical Biochemistry. 42(10-11). 1162–1165. 4 indexed citations
7.
Wong, Donald & Walter Korz. (2008). Translating an Antagonist of Chemokine Receptor CXCR4: From Bench to Bedside. Clinical Cancer Research. 14(24). 7975–7980. 154 indexed citations
8.
Hotte, Sébastien J., et al.. (2008). 405 POSTER Final results of a Phase I/II study of CTCE-9908, a novel anticancer agent that inhibits CXCR4, in patients with advanced solid cancers. European Journal of Cancer Supplements. 6(12). 127–127. 25 indexed citations
9.
Wong, Donald, Walter Korz, & Hassan Salari. (2007). Anticancer effect of a combination of CXCR4 antagonist CTCE-9908 and Docetaxel in a murine model of human prostate cancer. Molecular Cancer Therapeutics. 6. 3 indexed citations
10.
Hotte, Sébastien J., et al.. (2007). Phase I/II study of CTCE-9908, a novel anticancer agent that inhibits CXCR4, in patients with advanced solid cancers. Molecular Cancer Therapeutics. 6. 11 indexed citations
11.
Kim, Su Young, Brieanne Midura, Choh Yeung, et al.. (2007). Inhibition of the CXCR4/CXCL12 chemokine pathway reduces the development of murine pulmonary metastases. Clinical & Experimental Metastasis. 25(3). 201–211. 202 indexed citations
12.
Wong, Donald, Walter Korz, Ahmed Merzouk, & Hassan Salari. (2006). A peptide antagonist of chemokine receptor CXCR4 reduces tumor metastasis in a murine orthotopic model of human prostate cancer. Cancer Research. 66. 511–511. 6 indexed citations
13.
Korz, Walter, et al.. (2006). A Stromal cell Derived Factor 1 (SDF-1) agonist stimulates neutrophil mobilization in normal humans after subcutaneous injection. Biology of Blood and Marrow Transplantation. 12(2). 105–106. 1 indexed citations
14.
Kim, Su Young, Brieanne Midura, Arnulfo Mendoza, et al.. (2006). In vitro and in vivo effects of CXCR4 inhibition in osteosarcoma. 66. 67–67. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026